Capstone Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Capstone Investment Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,567	Closed	-$2.57M	–	2124
2021 Q2	$2.57M	Sell	15,567 -12,933	-45%	-$2.16M	0.01%	940
2021 Q1	$4.37M	Buy	+28,500	New	+$3.87M	0.01%	686
2017 Q4	–	Sell	-9,560	Closed	-$728K	–	703
2017 Q3	$728K	Buy	+9,560	New	+$723K	0.03%	261
2017 Q1	–	Sell	-9,000	Closed	-$496K	–	1190
2016 Q4	$496K	Buy	+9,000	New	+$494K	0.02%	587
2016 Q3	–	Sell	-5,372	Closed	-$224K	–	958
2016 Q2	$224K	Buy	+5,372	New	+$247K	﹤0.01%	611

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Capstone Investment Advisors's PRAH Position: Q3 2021 in Review

Capstone Investment Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 15,567 shares — an estimated $2.57M sold.

Capstone Investment Advisors first reported a position in PRAH in Q2 2016 and held it in 5 quarters. The position peaked at $4.37M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Capstone Investment Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Capstone Investment Advisors sold 15,567 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.57M.
Capstone Investment Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 5 quarters.
Capstone Investment Advisors's PRA Health Sciences, Inc. position peaked at $4.37M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Capstone Investment Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.